Docencia

Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial

Dra. Joana Vitalle Andrade
Instituto de Biomedicinade Sevilla(IBiS)
Hospital Universitario Virgen del Rocio

Efficacy, safety, and tolerabilityof switchingto long-actingcabotegravirplus rilpivirineversus continuingfixed-dosebictegravir, emtricitabine…

Dr. Javier García Abellán
Unidad de Enfermedades Infecciosa
Hospital General Universitario de Elche

Curso de introducción a R: Herramientas para el análisis de datos clínicos y virológicos

Web: Acceder

Contenido del curso: Acceder

Curso Writing in the Science

Programa: Ver

Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study (23/06/2023)

Dr. Oskar Ayerdi Aguirrebengoa
Centro Sanitario Sandoval, IdISSC.
Hospital Clínico San Carlos, Madrid.

Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial (09/06/2023)

Dra. Verónica Briz
Centro Nacional de Microbiología Instituto de Salud Carlos III.

Effects of clinical, comorbid, and social determinants of health on brain ageing in people with and without HIV: a retrospective case-control study (26/05/2023)

Dra. Isabel A. Pérez Hernández
Unidad de Enfermedades Infecciosas.
Hospital Universitario Virgen de la Victoria, Málaga.

Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections (12/05/2023)

Dr. Boris Revollo B.
MD, PhD Germans Trias i Pujol University Hospital.
Infectious Diseases Department.
Fight Infections Foundation.

Página 1 de 181 2 3 18

Accesos directos